Cost-Effectiveness Analysis of Secukinumab in Ankylosing Spondylitis- A Canadian Perspective
Oct 1, 2017, 00:00 AM
10.1016/j.jval.2017.08.764
https://www.valueinhealthjournal.com/article/S1098-3015(17)31098-7/fulltext
Section Title :
Disease-Specific Studies
Section Order :
729
First Page :
A533
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31098-7&doi=10.1016/j.jval.2017.08.764